Aytu BioPharma Receives Orphan Drug Designation from FDA for AR101 for Treatment of Vascular Ehlers-Danlos Syndrome

3 years ago

ENGLEWOOD, CO / ACCESSWIRE / December 8, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing…

Philips receives FDA 510(k) clearance for its most advanced acute patient monitors

3 years ago

Patient Monitors IntelliVue MX750 and IntelliVue 850 are Philips most advanced patient monitors yet Patient Monitors IntelliVue MX750 and IntelliVue…

Radius Announces Results from the wearABLe Trial Evaluating Abaloparatide Transdermal System in Postmenopausal Women with Osteoporosis

3 years ago

The wearABLe study did not demonstrate non-inferiority of abalo-TDS to TYMLOS®Lumbar spine BMD at 12 months vs. baseline for abalo-TDS…

Radius Health to Host Conference Call Today, Wednesday, December 8, 2021

3 years ago

BOSTON, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS) announced it will host…

Jasper Therapeutics to Present Data on JSP191 Conditioning in SCID patients at the 2021 American Society of Hematology Annual Meeting

3 years ago

JSP191 is well tolerated with no treatment-related adverse events in dose-escalation studySingle-agent conditioning with JSP191 is associated with engraftment, immune…

Checkpoint Therapeutics Announces Initiation of CONTERNO Phase 3 Trial of Cosibelimab Combined with Chemotherapy in Patients with First-Line Non-Squamous Non-Small Cell Lung Cancer

3 years ago

WALTHAM, Mass., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology…

Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device

3 years ago

ROCKVILLE, Md., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company focused on developing and…

Augmedix Inc. (NASDAQ: AUGX) Leveraging ASR, NLP Tech to Rehumanize Healthcare

3 years ago

NEW YORK, Dec. 08, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Augmedix Inc. (NASDAQ: AUGX) today announces its placement in…

Sugarmade Provides Corporate Update as Nug Avenue Sees Accelerating Growth Ahead of Further Expansion

3 years ago

NEW YORK, NY, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Sugarmade, Inc. (OTC Pink: SGMD) ("Sugarmade", "SGMD" or the "Company") an…

Stereotaxis Robotic Technology Reduces Incidence of Silent Cerebral Embolism During Atrial Fibrillation Ablation in New Peer-Reviewed Publication

3 years ago

ST. LOUIS, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment…